Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharmacology > Autonomic Pharmacology > Flashcards

Autonomic Pharmacology Flashcards

1
Q

the autonomic NS (ANS) regulates…

A

ANS regulates visceral functions that occur w/out conscious control.

all visceral organs are innervated by ANS except skeletal muscles, being under the control of the somatic NS (SNS)

cardiovascular
respiratory
digestive
urinary
reproductive
**key role in the body's response to stress
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

the ANS originates from?

A

from the CNS (brain & SC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the 2 divisions of the ANS?

A

sympathetic and parasympathetic

based on the type of efferent nerves

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

sympathetic vs. parasympathetic systems

A

constant opposition to each other

SYMPATHETIC:
allows body to function under stress
fight or flight
short neuron pathways- quick

PARASYMPATHETIC:
controls vegetative functions
main regulator of automatic functions
neuron pathways are much longer- slower system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

effects of stimulating the sympathetic system..

A

dilates pupils

inhibits salivation

relaxes bronchi

accelerates heart

inhibits digestive activity

stimulates glucose release by liver

secretion of epinephrine & norepinephrine form kidney

relaxes bladder

contracts rectum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

effects of stimulating the parasympathetic system…

A

constricts pupil

stimulates salivation

inhibits heart

constricts bronchi

stimulates digestive activity

stimulates gallbladder

contracts bladder

relaxes rectum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

anatomically the sympathetic fibers originate from?

A

the first thoracic to the second/third lumbar segments of the SC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

anatomically the parasympathetic fibers originate from?

A

the midbrain, medulla oblongata, and the sacral part of the SC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is autonomic ganglia?

A

specialized complex structures residing outside the SC that contain axodendritic synapses between pre-ganglionic and post-ganglionic neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is a neurotransmitter?

A

a chemical substance which travels across a synaptic junction to act on a target cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are 2 types of neurotransmitters?

A

1- acetylcholine (Ach)

2- norepinephrine (NE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is acetylcholine (Ach)?

A

the neurotransmitter in the autonomic ganglia (pre-ganglionic neurotransmitter) of both the sympathetic and parasympathetic divisions

the neurotransmitter at the neuro-effector junction (post-ganglionic neurotransmitter) of the parasympathetic system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

acetylcholine (Ach) is synthesized in the neurons from:

A

acetyl CoA and choline by choline actyltransferase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

acetylcholine (Ach) is broken down in:

A

the ganglionic junction or the neuro-effector junction by acetylcholine esterase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is norepinephrine (NE)?

A

the neurotransmitter at the neuro-effector junction (post-ganglionic neurotransmitter) of the sympathetic division

NE does not get broken down but rather is re-uptaken by the pre-synaptic fiber- a process mediated by pre-synaptic a2 receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

NE belongs to a group of endogenous chemicals called:

A

catecholamines

include dopamine and epinephrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

SLIDE 9

A

???

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Ach’s effects are mediated through 2 subtypes of receptors:

A

1- muscarinic (M)

2- nicotinic (N)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

muscarinic (M) receptors are present in..

A

in the neuro-effector junction (post-ganglia) of the parasympathetic division

7 different receptors- if you stimulate 1 you automatically stimulate all the others

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

nicotinic (N) receptors are present in..

A

the autonomic ganglia (pre-ganglia) of BOTH sympathetic and parasympathetic divisions of the ANS and in the neuromuscular junction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

NE and epinephrine’s effects are mediated by 2 receptor subtypes:

A

alpha and beta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

alpha receptors are either:

A

alpha1

or

alpha2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

alpha1 receptors are present in the:

A

arteriolar smooth muscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

activation of a1 receptors leads to:

A

vasoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

alpha2 receptors are found:

A

pre-ganglionically and in the CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

activation of a2 receptors leads to:

A

decrease in the sympathetic flow from CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

beta receptors are either:

A

beta1

or

beta2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

beta1 receptors are found in:

A

the heart and kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

activation of B1 receptors leads to:

A

increase HR (chronotropic), force of contraction (inotrophic), and release of renin from kidney (increases BP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

beta2 receptors are found in:

A

smooth muscles of blood vessels and bronchi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

activation of B2 leads to:

A

vasodilation and bronchodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

adrenergic impulses from the

A

sympathetic system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

cholinergic impulses from the

A

parasympathetic system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

adrenergic vs cholinergic impulses on effector organs

A

slides 13-18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

parasympathomimetics:

A

mimic the effects of parasympathetic nerve stimulation

muscarinic receptor agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

direct acting parasympathomimetics:

A

directly stimulates the muscarinic receptor

mechanism of action: stimulation of M receptors at the neuro-effector junction w/ no or little N receptor stimulation

ACh is not commonly used because it is hydrolyzed rapidly by plasma pseudocholine esterase (broken down right away in the blood)

ex: methacholine, carbachol, bethanchol, pilocarpine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

4 therapeutic uses for muscarinic receptor agonists

A

1- GI disorders
bethanchol can be of value in post-op abdominal distention & gastric atony

2-urinary bladder disorders
muscarinic agonists can be useful in combating urinary retention & inadequate emptying of the bladder when organic obstruction is absent, as in post-op and postpartum urinary retention

3-Xerostomia
pilocarpine can be administered orally for the tx of dry mouth that follows head & neck radiation txs or that is associated w/ Sjorgen syndrome, an autoimmine disorder in women associated w/ dryness of lacrimal and salivary secretions are compromised

4-Opthalmological
pilocarpine is also used in tx of glaucoma, it is able to reverse an acute narrow angle glaucoma and overcoming mydriasis produced by atropine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

what is ACh esterase?

A

the enzyme that breaks down ACh

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Indirect-acting parasympathomimetrics

A

these agents do not stimulate the M receptors but prolong the duration of action of endogenous Ach by inhibiting ACh esterase- the enzyme that breaks down ACh

(prevents breakdown of acetylcoline by blocking th enzyme response)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

reversible inhibitors of ACh esterase:

A

carbamates

physostigmine
neostigmine
pyridostigmine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

therapeutic uses for indirect acting parasympathomimetics:

A

similar to direct acting agents

in addition, they are used in myasthenia gravis, and paralytic ileum

Donepezil (Aricept) is used to manage the dementia associated w/ Alzheimer disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

irreversible ACh esterase inhibitors include:

A

organophosphorous insecticides:

paraxon
malaoxon
nerve gas sarin

these agents have no therapeutic uses: intoxication symptoms can vary from increased secretions to tremors and respiratory collapse.
To counteract the effects of these agents, atropine (M receptor blocker) and pralidoxime (2-PAM) is usually given. 2-PAM salvages the ACh esterase before the binding of the organophosorous to the enzyme becomes permanent.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

precautions, toxicity and contra-indications of muscarinic agonists:

A

serious toxic reactions to muscarinic agonists can be treated with ATROPINE SULFATE either subcutaneously or intravenously.

Epinephrine can also be of value in overcoming severe cardiovascular or bronchoconstrictor responses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

mechanism of action of muscarinic receptor antagonists?

A

competitive blocking of muscarinic receptors at the neuro-effector sites on smooth muscle, cardiac muscle, gland cells, in the CNS with little blockade of the effects of ACh at nicotinic receptor sites

muscarinic receptor blockers show little or no selectivity towards the different muscarinic receptor subtypes (M1, M2, M3) with the exception of Pirenzepine that possess relative selectivity towards M1 receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

muscarinic receptor antagonists pharmacological properties on cardiovascular system:

A 
HEART: 
increases HR (tachycardia) by blocking the vagal nerve effects on M2 receptors on the SA nodal pacemaker

BLOOD VESSELS:
when given alone, muscarinic receptor antagonists do not affect the vascular smooth muscle contractility due to the absence of parasympathetic control of the vascular system.
** but if choline esters are administered, muscarinic blockers can block vasodilation induced by choline esters effects on endothelial M3 receptors

46
Q

muscarinic receptor antagonists pharmacological properties on the respiratory tract:

A

parasympathetic nerve stimulation plays a major role in regulating broncomotor tone. stimulation of M3 receptor causes bronchoconstriction.

muscarinic receptor blockers induce BRONCHODILATION.

futhermore, muscarinic blockers inhibit secretions of the nose, pharynx and bronchi- thus drying mucous membrane of the respiratory tract

47
Q

muscarinic receptor antagonists pharmacological properties on the GI tract:

A

inhibit GI motility and secretions

inhibit gastric acid secretion induced by parasympathetic nerve stimulation

48
Q

muscarinic receptor antagonists pharmacological properties on the urinary tract:

A

decreases the tone and amplitude of contractions of ureter and bladder

49
Q

muscarinic receptor antagonists pharmacological properties on the sweat glands:

A

inhibition of sweating leading to skin becoming hot and dry

high doses may raise the body temperature in response to inhibition of sweating

50
Q

muscarinic receptor antagonists pharmacological properties on the CNS:

A

effects on the CNS depend on the ability of the drug to cross the BBB

at higher than therapeutic doses, atropine causes central excitation, leading to restlessness, hallucinations, and delirium. This excitation is followed by CNS depression.

Scopolamine, in therapeutic doses, causes CNS depression manifested as drowsiness, amnesia, fatigue

51
Q

muscarinic receptor antagonists pharmacological properties on the eye:

A

mydriasis- dilation of the pupil

cycloplegia- paralysis of the ciliary eye muscle

52
Q

what is atropine?

A

medication used to decrease saliva and phlegm to control stomach/intestinal spasms.

works by blocking ACh

53
Q

effects of 0.5mg of atropine

A

inhibition of sweating, some dryness of mouth

54
Q

effects of 1mg of atropine

A

definite dryness of mouth, heart acceleration, mild pupil dilation

55
Q

effects of 2 mg of atropine

A

rapid heart rate, palpitations, marked dilation of pupils

56
Q

effects of 5 mg of atropine

A

all of the above symptoms +

inhibition of parasympathetic control of GI, urinary bladder, inhibition of gastric secretions and motility

57
Q

effects of >10mg of atropine

A

in addition to above symptoms,

CNS involvement is evident: restlessness, excitement, hallucinations, delirium, coma

58
Q

therapeutic uses for muscarinic receptor antagonists

A

Ipratropium bromide (atrovent):

a muscarinic receptor blocker devoid of CNS activity

principal use is a bronchodilator in chronic obstructive pulmonary disease (COPD) and to a lesser extent in asthma

homatropine, hydrobromide, cyclopentolate, tropicamide
These drugs are used as mydriatic agents necessary for thorough examination of retina and optic discs. These drugs are preferred over atropine because of the duration of action

overactive bladder

59
Q

scopolamine (transderm scop) is?

A

owing to its ability to cross the BBB

has been used prophylactically to control motion sickness for durations up to 72 hours.

common side effects include:
dry mouth
loss of visual accommodation

60
Q

what is atropine?

A

used as xerostomic in conditions of salivary hyper secretions

pre-operatively to reduce mucus membrane secretions

protect against reflex bradycardia

can be used as an antidote for mushroom poisoning

61
Q

muscarinic receptor antagonists used for overactive bladder:

A

tolterodine tartrate (detrol): approved for symptoms associated with overactive bladder

fesoterodine fumarate (Toviaz): recently approved pro-drug for the tx of overactive bladder

62
Q

parasympatholytics=

A

receptor antagonists

63
Q

parasympathomimetics=

A

receptor agonists

64
Q

side effects and toxicity of muscarinic receptor antagonists

A 
dryness of mouth
urinary retention
anhydrosis- absence of sweat
tachycardia
palpitations
constipation
65
Q

sympathomimetic agents

A

these drugs exert their effects via direct stimulation of the adrenergic receptors (a1, a2, B1, B2) leading to a widerange of pharmacological effects

66
Q

endogenous sympathomimetric drugs include:

A

epinephrine (adrenaline)
norepinephrine (nonadrenaline)
dopamine

67
Q

cardiac effects of epinephrine

A

through stimulation of B1 receptors, epinephrine has a positive chronotropic and positive inotropic effects

68
Q

respiratory effects of epinephrine

A

through stimulation of B2 receptors, epinephrine has a potent bronchodilator effect (relaxation of bronchial smooth muscles)

69
Q

epinephrine has a short duration of action because..

A

it is rapidly metabolized by enzymes

monoamine oxidase (MAO) and catechol-O-methyltransferase (COMT).

70
Q

routes of administering epinephrine:

A

epinephrine is not active when given orally because it is rapidly metabolized by enzymes

rapid intravenous injection of epinephrine may result in cerebral hemorrhage from the sharp rise in BP

other serious effects include: 
tremors
palpitations
anxiety
restlessness
71
Q

therapeutic uses for epinephrine?

A

provide rapid relief of hypersensitivity reactions including anaphylaxis to drugs and allergens

restore cardiac rhythm in patients with cardiac arrest due to various causes

72
Q

epinephrine has a higher affinity for?

A

beta receptors

73
Q

norepinephrine has a higher affinity for?

A

alpha receptors

specifically a1

74
Q

pharmacological effects of norepinephrine?

A

NE is a more powerful activator of a1 receptors than epinephrine is, but a much weaker activator of B2 receptors.

therefore, NE increases BP more than epinephrine. The net effect of epinephrine on BP would be a balance between its a1 and B2 effects.

NE is not useful as a bronchodilator

75
Q

therapeutic uses of epinephrine

A

can be titrated to the desired pressor effect in treatment of hypotension

76
Q

route of administrating NE

A

NE is not active orally and is subject to the same metabolic pathways as that of epinephrine

77
Q

what receptor does dopamine use? and what are the pharmacological effects of dopamine?

A

dopamine is in the synthetic pathway to NE and epinephrine. It is a central neurotransmitter and has the ability to act as an agonist on its own receptor- DOPAMINE RECEPTOR

at low doses, activation of D1 receptors in the renal, coronary, and mesenteric beds leads to VASODILATION

at higher doses, dopamine can stimulate cardiac B2 RECEPTORS leading to positive inotropic and chronotropic effects

78
Q

therapeutic uses of dopamine?

A

used in treatment of severe CHF, particularly in patients with oligurea and with low or normal peripheral vascular resistance

79
Q

what is CHF?

A

decreased CO that leads to fluid retention and an increase in peripheral resistance

80
Q

how does dopamine act to treat CHF?

A

by dilating renal arteries (D1 vasodilates, B2 bronchodilates)–> increases renal profusion –> increase urine output –> alleviates the fluid retention problem in CHF

81
Q

what are dopamine related drugs?

A

Fenoldopam (Corlopam, A synthetic D-1-selective agonist with no effect towards a or B receptors

indicated for short term management of severe HTN where rapid reduction of BP is clinically indicated

82
Q

2 non-selective B agonists:

A

ISOPRETRENOL

isuprel

83
Q

what is isoprotrenol?

A

a potent NON-SELECTIVE B AGONIST with no a agonist effects

cardiac effects include:
increased CO do to positive inotropic & chronotropic effects
dilation of muscle and mesenteric arteries

84
Q

therapeutic uses for non-selective B agonists-Isoprotrenol

A

in emergencies to stimulate HR in patients with bradycardia or heart block

85
Q

B2 selective agonists

A

higher preferential affinity towards B2 receptors with little or no effects on B1 receptors.

ex: treatment of asthma, B2 is ideal

this selectivity has been realized although at high doses of these drugs, the selectivity is lost!!

86
Q

short-acting B2 agonists:

A

albuterol (venotolin)
terbutaline (Brethine)

these drugs have a rapid onset of action (15 min)
short duration of action (4-6 hours)

87
Q

alpha adrenergic receptor agonists work by stimulating…

A

either a1 or a2 receptors

88
Q

uses for a1 selective agonists

A

NASAL DECONGESTANTS: in patients with allergic rhinitis. The effect is through constriction of blood vessels in nasal tissues leading to decreased BF –> decreased fluid accumulation in nasal tissues

ex: Oxymetazoline (Afrin), Phenylephrine, Mephentermine

chronic use of nasal decongestants leads to loss of efficacy and worsening of congestion symptoms. This is due to RECEPTOR DESENSITIZATION

89
Q

what is receptor desensitization?

A

chronic use leads to loss of efficacy and worsening of symptoms

90
Q

a2 selective agonists?

A

Clonidine (Catapres)
this drug selectively stimulates a2 adrenergic receptor in the CNS. This effect results in a decrease in central sympathetic outflow (decreased norepinephrine –>decreased BP)

91
Q

therapeutic uses of a2 selective agonists?

A

treatment of hypertension (a2 decreases NE; NE increases a1- increases HR and force)

92
Q

miscellaneous adrenergic agonists

A

Amphetamine, dextroamphetamine (Dexedrine), methylphenidate (Ritalin)

Pharmalogical effects:
CNS stimulant effect: this effect is mediated by the ability of these drugs to release NE in the CNS

Uses: dextroamphetemine and methylphenidate are used in tx of ADHD

93
Q

adrenergic receptor antagonists:

A

this class of drugs exhibit its effects via competitive blockade of a and/or B adrenergic receptors

94
Q

alpha adrenoceptor blockers:

A

Phenoxybenzamine (Dibezyline)
irreversible blocker of a1 and a2 receptors with a slight selectivity towards a1 receptors
Used to treat pheocromocytoma

Phentolamine (regitine): non-selective reversible

Tolazoline (Priscoline): non-selective reversible
used in newborns to treat persistent pulmonary HTN

95
Q

name 2 non-selective reversible alpha blockers

A

phentolamine (regitine)

tolazoline (priscoline)

96
Q

what is phentolamine?

A

non-selective reversible alpha-blocker

used in the short term to control HTN in patients with pheocromocytoma (benign adrenal gland cancer that produces too many hormones- increases HR and BP)

97
Q

a1 selective blockers examples:

A

Prazosin (Minipress)
Terazosin (Hytrin)
Doxazosin (Cardura)

98
Q

pharmacological effects of a1 selective blockers:

A

blocking of a1 receptors in vascular smooth muscles of arterioles and veins

decreases peripheral resistance

tachycardia is less observed with these drugs compared to non-selective alpha blockers

99
Q

2 adverse effects of a1 selective blockers:

A

1- First-dose phenomenon: marked postural hypotension and syncope observed 60-90 minutes after first dose

2- these drugs, owning to their vasodilating effect, can promote water retention

100
Q

therapeutic uses of a1 selective blockers:

A

treatment of primary systemic hypertension

101
Q

what is the effect on the heart from B adrenergic receptor blockers?

A

blocking of B1 receptors leads to slowing of HR and decreasing myocardial contractility

102
Q

what is the effect on the pulmonary system from B adrenergic receptor blockers?

A

blocking of B2 receptors has little effects on pulmonary function in normal individuals.
In patients with asthma or COPD, this can lead to life-threatening bronchoconstriction

103
Q

what is the effect on peripheral vascular resistance from B adrenergic receptor blockers?

A

blocking of B2 receptors in the arteriolar smooth muscle can lead to an increase in vascular resistance.

long term effect of B1 blocker use in HTN patients with high circulating renin levels is a reduction in peripheral vascular resistance

104
Q

non-selective B blockers examples:

A

these drugs reversibly block B1 and B2 receptors with no selectivity towards either

ex:
PROPRANOLOL (Inderal)

Nadolol (Corgard)

Timolol (Blocadren)

Pindolol (Viskin) also has the ability to produce a partial stimulation of the B receptor

Labetalol (Normodyne) and Carvedilol (Coreg): also posses a1 blocking activity. The a1 blocking activity would lead to some degree of decreased peripheral resistance beneficial in tx of HTN

105
Q

B1 selective blockers

A

at therapeutic doses show a higher selectivity towards B1 receptors more than B2

ex: 
Metoprolol (Lopressor)
Atenolol (Tenormin)
Esmolol (Brevibloc)
Acebutolol: also some agonist properties
106
Q

therapeutic uses for B1 selective blockers:

A

HTN

CHF

Angina and MI

107
Q

adverse effects of B1 selective blockers:

A

in patients with AV conduction defects, B1 blockers may cause life threatening bradyarrhythmias

abrupt discontinuation of long term B1 blockers use in angina can exacerbate angina and may increase risk of sudden MI

B2 receptor blockade can worsen bronchoconstriction in asthmatic populations.
*B1 selective blockers or non-selective B blockers w/ partial B2 agonism produce less bronchoconstriction than non-selective B blockers.

108
Q

what is clonidine?

A

alpha2 selective agonist

by means of CNS decreases NE–> decreases BP

109
Q

what is succinylcholine?

A

the only depolarizing skeletal muscle relaxant. It blocks reach ACh from going to the receptor. It works on the neuromuscular junction therefore has no effect on cardiac or smooth muscle

110
Q

increased renin leads to?

A

increased vasoconstriction –> increased BP

Pharmacology (8 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions